Cardiff Oncology, Inc.
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a CRDF research report →
About the company
Cardiff Oncology, Inc. , a clinical-stage biotechnology company, develops novel therapies for the treatment of various cancers in the United States. Its lead drug candidate is Onvansertib, an oral and selective polo-like kinase 1 inhibitor for treating RAS-mutated metastatic colorectal cancer.
- CEO
- Mani Mohindru
- IPO
- 2004
- Employees
- 31
- HQ
- San Diego, CA, US
Price Chart
- Market Cap
- $86.83M
- P/E
- -1.90
- P/S
- 165.39
- P/B
- 2.50
- EV/EBITDA
- -1.80
- Div Yield
- 0.00%
- Gross Margin
- -2105.71%
- Op Margin
- -9033.90%
- Net Margin
- -8526.10%
- ROE
- -95.50%
- ROIC
- -134.15%
- Revenue
- $593.00K · -13.18%
- Net Income
- $-45,851,000 · -0.92%
- EPS
- $-0.69 · 27.37%
- Op Income
- $-48,960,000
- FCF YoY
- -0.51%
- 52W High
- $4.56
- 52W Low
- $1.16
- 50D MA
- $1.56
- 200D MA
- $1.99
- Beta
- 1.38
- Avg Volume
- 1.22M
Get TickerSpark's AI analysis on CRDF
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Recent insider transactions
Who's buying, who's selling, and how much.
| Date | Insider | Type | Shares |
|---|---|---|---|
| Jun 18, 26 | Mohindru Mani | buy | 24,703 |
| Jun 18, 26 | PACE GARY W | buy | 30,000 |
| Jun 11, 26 | Armitage James O | other | 40,565 |
| Jun 11, 26 | White Lale | other | 40,565 |
| Jun 11, 26 | TANNENBAUM RENEE P | other | 40,565 |
| Jun 11, 26 | Markin Rodney S | other | 40,565 |
| Jun 11, 26 | PACE GARY W | other | 40,565 |
| Apr 27, 26 | Aggarwal Ajay | other | 400,000 |
| Apr 27, 26 | Aggarwal Ajay | other | 0 |
| Apr 6, 26 | Muntner Joshua B | other | 0 |
Our CRDF coverage
Recent articles, reports, and earnings notes.
No research on CRDF yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate CRDF report →Similar companies
Peers in the same neighborhood.